184 related articles for article (PubMed ID: 19574678)
1. Positron emission tomography / computerized tomography evaluation of primary Hodgkin's disease of liver.
Gota VS; Purandare NC; Gujral S; Shah S; Nair R; Rangarajan V
Indian J Cancer; 2009; 46(3):237-9. PubMed ID: 19574678
[TBL] [Abstract][Full Text] [Related]
2. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
3. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
[TBL] [Abstract][Full Text] [Related]
4. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
[TBL] [Abstract][Full Text] [Related]
5. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
[TBL] [Abstract][Full Text] [Related]
6. Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET.
Altamirano J; Esparza JR; de la Garza Salazar J; Calvo PS; Vera SR; Chalapud Revelo JR; Estrada G
Arch Med Res; 2008 Jan; 39(1):69-77. PubMed ID: 18067998
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography/computerized tomography in the evaluation of primary non-Hodgkin's lymphoma of prostate.
Pan B; Han JK; Wang SC; Xu A
World J Gastroenterol; 2013 Oct; 19(39):6699-702. PubMed ID: 24151402
[TBL] [Abstract][Full Text] [Related]
8. PET imaging in pediatric Hodgkin's lymphoma.
Hudson MM; Krasin MJ; Kaste SC
Pediatr Radiol; 2004 Mar; 34(3):190-8. PubMed ID: 14745528
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease.
Wiedmann E; Baican B; Hertel A; Baum RP; Chow KU; Knupp B; Adams S; Hör G; Hoelzer D; Mitrou PS
Leuk Lymphoma; 1999 Aug; 34(5-6):545-51. PubMed ID: 10492078
[TBL] [Abstract][Full Text] [Related]
10. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases.
Molin D; Hagberg H; Suurküla M; Aström G
Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779
[No Abstract] [Full Text] [Related]
11. [Primary non-Hodgkin lymphoma of the liver: case report and review of the literature].
Nasr Ben Ammar C; Chaari N; Kochbati L; Besbes M; Maalej M
Cancer Radiother; 2006 Dec; 10(8):595-601. PubMed ID: 17137818
[TBL] [Abstract][Full Text] [Related]
12. ¹⁸F-fluorodeoxyglucose PET/CT findings of a solitary primary hepatic lymphoma: a case report.
Pan B; Wang CS; Han JK; Zhan LF; Ni M; Xu SC
World J Gastroenterol; 2012 Dec; 18(48):7409-12. PubMed ID: 23326154
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the diagnosis and follow-up of primary hepatic diffuse large B-cell Lymphoma: A clinical case report.
Wang L; Dong P; Hu W; Tian B
Medicine (Baltimore); 2020 Jan; 99(5):e18980. PubMed ID: 32000430
[TBL] [Abstract][Full Text] [Related]
14. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.
Crocchiolo R; Fallanca F; Giovacchini G; Ferreri AJ; Assanelli A; Verona C; Pescarollo A; Bregni M; Ponzoni M; Gianolli L; Fazio F; Ciceri F
Ann Hematol; 2009 Dec; 88(12):1229-36. PubMed ID: 19468730
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: preliminary results of a prospective study.
Paolini R; Rampin L; Rodella E; Ramazzina E; Banti E; Al-Nahhas A; Rubello D
Nucl Med Rev Cent East Eur; 2007; 10(2):87-90. PubMed ID: 18228212
[TBL] [Abstract][Full Text] [Related]
16. (18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?
Iagaru A; Wang Y; Mari C; Quon A; Goris ML; Horning S; Gambhir SS
Hell J Nucl Med; 2008; 11(3):153-6. PubMed ID: 19081857
[TBL] [Abstract][Full Text] [Related]
17. 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.
Rigacci L; Castagnoli A; Dini C; Carpaneto A; Matteini M; Alterini R; Carrai V; Nassi L; Bernardi F; Pieroni C; Bosi A
Oncol Rep; 2005 Nov; 14(5):1209-14. PubMed ID: 16211287
[TBL] [Abstract][Full Text] [Related]
18. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
Chiusolo P; Sica S; Leone G
Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
[TBL] [Abstract][Full Text] [Related]
19. Functional imaging of Hodgkin's disease with FDG-PET and gallium-67.
Willkomm P; Palmedo H; Grünwald F; Ruhlmann J; Biersack HJ
Nuklearmedizin; 1998; 37(7):251-3. PubMed ID: 9830616
[TBL] [Abstract][Full Text] [Related]
20. Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma.
Puyade M; Yacoub M; Tomowiak C; Diviné M; Perdrisot R; Guilhot F; Delwail V
Acta Haematol; 2013; 129(4):229-31. PubMed ID: 23328622
[No Abstract] [Full Text] [Related]
[Next] [New Search]